Click here to view Ms. Sundeen's bio in Chinese
Marcia H. Sundeen, Chair of the firm’s International Trade Commission (“ITC”) Practice, has the experience and advocacy skills that clients seek when their critical intellectual property assets are at issue. With more than 25 years of experience crafting litigation strategies that have facilitated client victories before the U.S. district courts and the ITC, Ms. Sundeen is an accomplished litigator whose abilities have led to her recognition in Chambers USA and Intellectual Asset Management’s Patent 1000 as being amongst the top ITC practitioners in the field.
As a former ITC attorney, Ms. Sundeen gained her stature as one of the nation’s leading ITC attorneys by demonstrating an insider’s understanding of the Commission’s culture and an in-depth knowledge of the substantive and procedural complexities of Section 337 ITC actions. She is a former President of the ITC Trial Lawyers Association and a co-author and editor of the de facto treatise on Section 337, Unfair Competition and the ITC. Realizing the advantages to be derived from this level of experience and expertise, numerous clients have selected Ms. Sundeen to act as lead counsel in their ITC actions. Likewise, conference organizers around the world have invited Ms. Sundeen to speak at ITC-related conferences. Her recent speaking engagements include the American Conference Institute’s Forum on ITC Litigation and Enforcement, and LexisNexis’s 2nd Annual Pharma and Biotech Patent Conference 2010 in Shanghai, China, where she spoke on “Section 337 Actions and Preparing a Successful Defense.”
Beyond litigation, Ms. Sundeen advises clients on global patent enforcement and prosecution strategies and represents clients before the U.S. Customs Service and the Office of the U.S. Trade Representative. In addition, she develops intellectual property and food and drug strategies for biomedical device and pharmaceutical companies and lectures on Hatch-Waxman issues. She has authored a number of legal and technical publications, and is a co-inventor on U.S. Patent No. 4,293,719.